Published in Cancer Weekly, November 23rd, 1998
Research based on conventional cytogenetic studies of tumor cells from patients with breast or ovarian cancer have shown multiple chromosomal abnormalities including chromosomes 7, 12, and 17. H. Engel and colleagues from the University of Cologne, Germany, examined these abnormalities to better understand prognostic factors associated with gynecological cancers ("Detection of Chromosomal Aberrations in Tumor Cells and Tumor Infiltrating Lymphocytes by Molecular Cytogenetics in Patients with Gynecological Cancer," Cancer Genetics and Cytogenetics, October 15, 1998;106(2):159-165).
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.